Neuroendovascular Non-coils Market Size, Share and Growth Outlook 2026: By Product Type, By Material, By Application, By End-User, Companies to 2034
The global Neuroendovascular Non-coils Market size is forecast to increase from $1.88 Billion in 2026 to $2.74 Billion in 2034 at a CAGR of 4.8% between 2026 and 2034.
The Neuroendovascular Non-coils market report provides detailed analysis and outlook of Neuroendovascular Non-coils segments including By Product Type (Neuroendovascular Stents, Flow Diversion Devices, Thrombectomy Devices, Access Devices, Liquid Embolic Agents, Embolic Protection Devices, Balloon Catheters), By Material (Nitinol-based Devices, Cobalt-chromium-based Devices, Polymer-based Devices), By Application (Ischemic Stroke Management, Intracranial Aneurysm Treatment, Arteriovenous Malformation (AVM) and Fistulas, Carotid Artery Disease), By End-User (Hospitals and Integrated Cath Labs, Dedicated Stroke Centers, Ambulatory Surgical Centers (ASCs)) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
Neuroendovascular Non-coils Industry Overview
Flow Diversion and Mechanical Neurovascular Technologies Are Expanding Treatment Options
The neuroendovascular non-coils industry is evolving rapidly as neurointerventional specialists increasingly adopt flow diverters, embolization devices, thrombectomy systems, and vascular reconstruction technologies for the treatment of intracranial aneurysms and acute ischemic stroke. Unlike traditional coil-based therapies, non-coil neurovascular devices are designed to reconstruct diseased vessels, redirect blood flow, restore vessel patency, and promote long-term vascular healing through advanced implant engineering. Growing procedural volumes, expanding neurointerventional capabilities, and increasing demand for minimally invasive treatment approaches are accelerating adoption across comprehensive stroke centers and specialized neurovascular hospitals. Manufacturers are focusing on device flexibility, thrombogenicity reduction, vessel-wall integration, and procedural reliability to improve outcomes in complex cerebrovascular conditions.
Advanced Flow Diverters Are Driving Innovation in Aneurysm Management
Flow diversion technologies have become one of the most important segments within the neuroendovascular non-coils market. Stryker expanded its neurovascular portfolio through the global rollout of the Surpass Elite® Flow Diverter, a 64-wire cobalt-chromium implant engineered to redirect blood flow away from intracranial aneurysms while maintaining vessel reconstruction. The device incorporates BioStealth Surface technology, a proprietary surface modification designed to reduce fibrinogen adsorption and thrombin generation, addressing one of the key challenges associated with implanted neurovascular devices. Similarly, Medtronic strengthened its position in the aneurysm treatment market through deployment of the Pipeline™ Vantage Embolization Device with Shield Technology™. The self-expanding flow-diverting platform utilizes a biologically inspired surface treatment that lowers thrombogenicity while supporting aneurysm occlusion and vascular remodeling. These innovations highlight the industry's growing emphasis on biomimetic coatings, enhanced vessel healing, and long-term procedural safety.
Stroke Intervention Technologies Expand the Scope of Non-Coil Neurovascular Devices
Beyond aneurysm treatment, the market is benefiting from increasing adoption of mechanical devices for acute ischemic stroke intervention. Phenox received FDA clearance for its pRESET Delta and pRESET Delta LITE thrombectomy systems, expanding the range of available stent-retriever technologies used for clot removal in large intracranial arteries. These devices are engineered to mechanically engage and retrieve thromboembolic occlusions while supporting rapid restoration of cerebral blood flow during emergency stroke procedures. The growing integration of thrombectomy devices, flow diverters, embolization systems, and vessel reconstruction platforms demonstrates how the neuroendovascular non-coils industry is expanding beyond aneurysm management toward a broader neurovascular treatment ecosystem focused on minimally invasive intervention, procedural efficiency, and improved neurological outcomes.
Neuroendovascular Non-coils Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities
The global Neuroendovascular Non-coils market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Stryker Corporation, Medtronic plc, Johnson & Johnson MedTech (DePuy Synthes / Cerenovus), Terumo Corporation (MicroVention), Penumbra, Inc., Phenox GmbH (Wallaby Medical), Merit Medical Systems, Inc., MicroPort Scientific Corporation, Acandis GmbH, Balt USA LLC. The Neuroendovascular Non-coils market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Neuroendovascular Non-coils industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-
Leading companies in Neuroendovascular Non-coils industry include- Stryker Corporation, Medtronic plc, Johnson & Johnson MedTech (DePuy Synthes / Cerenovus), Terumo Corporation (MicroVention), Penumbra, Inc., Phenox GmbH (Wallaby Medical), Merit Medical Systems, Inc., MicroPort Scientific Corporation, Acandis GmbH, Balt USA LLC. The Neuroendovascular Non-coils market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.
What to expect in US Neuroendovascular Non-coils Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034
The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Neuroendovascular Non-coils market remains one of the strongest-performing segments in the country.
The US Neuroendovascular Non-coils Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Neuroendovascular Non-coils market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Neuroendovascular Non-coils industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.
Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Neuroendovascular Non-coils markets
Canada's strong Neuroendovascular Non-coils sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Neuroendovascular Non-coils market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.
Germany Neuroendovascular Non-coils Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.
Germany continues to remain the largest Neuroendovascular Non-coils market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Neuroendovascular Non-coils population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Neuroendovascular Non-coils industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Neuroendovascular Non-coils market outlook.
France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Neuroendovascular Non-coils sales through 2034
France Neuroendovascular Non-coils companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.
UK Neuroendovascular Non-coils Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain
Small high-need consumer segments remain key priority of Neuroendovascular Non-coils distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or ?280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was ?49 billion (14.1%) and voluntary health insurance was ?9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.
China Neuroendovascular Non-coils Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years
China Neuroendovascular Non-coils market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Neuroendovascular Non-coils industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Neuroendovascular Non-coils industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.
India Neuroendovascular Non-coils Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India
Indian Neuroendovascular Non-coils market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.
Brazil Neuroendovascular Non-coils market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities
Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.
Middle East and Africa Neuroendovascular Non-coils Industry Trends and Perspectives to 2034
According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.
Neuroendovascular Non-coils Market Segmentation
By Product Type
Neuroendovascular Stents
Flow Diversion Devices
Thrombectomy Devices
Access Devices
Liquid Embolic Agents
Embolic Protection Devices
Balloon Catheters
By Material
Nitinol-based Devices
Cobalt-chromium-based Devices
Polymer-based Devices
By Application
Ischemic Stroke Management
Intracranial Aneurysm Treatment
Arteriovenous Malformation (AVM) and Fistulas
Carotid Artery Disease
By End-User
Hospitals and Integrated Cath Labs
Dedicated Stroke Centers
Ambulatory Surgical Centers (ASCs)
Leading Companies in Neuroendovascular Non-coils Industry (2026)
Stryker Corporation
Medtronic plc
Johnson & Johnson MedTech (DePuy Synthes / Cerenovus)
Terumo Corporation (MicroVention)
Penumbra, Inc.
Phenox GmbH (Wallaby Medical)
Merit Medical Systems, Inc.
MicroPort Scientific Corporation
Acandis GmbH
Balt USA LLC
Countries Included
The Neuroendovascular Non-coils market report provides detailed analysis and outlook of Neuroendovascular Non-coils segments including By Product Type (Neuroendovascular Stents, Flow Diversion Devices, Thrombectomy Devices, Access Devices, Liquid Embolic Agents, Embolic Protection Devices, Balloon Catheters), By Material (Nitinol-based Devices, Cobalt-chromium-based Devices, Polymer-based Devices), By Application (Ischemic Stroke Management, Intracranial Aneurysm Treatment, Arteriovenous Malformation (AVM) and Fistulas, Carotid Artery Disease), By End-User (Hospitals and Integrated Cath Labs, Dedicated Stroke Centers, Ambulatory Surgical Centers (ASCs)) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
Neuroendovascular Non-coils Industry Overview
Flow Diversion and Mechanical Neurovascular Technologies Are Expanding Treatment Options
The neuroendovascular non-coils industry is evolving rapidly as neurointerventional specialists increasingly adopt flow diverters, embolization devices, thrombectomy systems, and vascular reconstruction technologies for the treatment of intracranial aneurysms and acute ischemic stroke. Unlike traditional coil-based therapies, non-coil neurovascular devices are designed to reconstruct diseased vessels, redirect blood flow, restore vessel patency, and promote long-term vascular healing through advanced implant engineering. Growing procedural volumes, expanding neurointerventional capabilities, and increasing demand for minimally invasive treatment approaches are accelerating adoption across comprehensive stroke centers and specialized neurovascular hospitals. Manufacturers are focusing on device flexibility, thrombogenicity reduction, vessel-wall integration, and procedural reliability to improve outcomes in complex cerebrovascular conditions.
Advanced Flow Diverters Are Driving Innovation in Aneurysm Management
Flow diversion technologies have become one of the most important segments within the neuroendovascular non-coils market. Stryker expanded its neurovascular portfolio through the global rollout of the Surpass Elite® Flow Diverter, a 64-wire cobalt-chromium implant engineered to redirect blood flow away from intracranial aneurysms while maintaining vessel reconstruction. The device incorporates BioStealth Surface technology, a proprietary surface modification designed to reduce fibrinogen adsorption and thrombin generation, addressing one of the key challenges associated with implanted neurovascular devices. Similarly, Medtronic strengthened its position in the aneurysm treatment market through deployment of the Pipeline™ Vantage Embolization Device with Shield Technology™. The self-expanding flow-diverting platform utilizes a biologically inspired surface treatment that lowers thrombogenicity while supporting aneurysm occlusion and vascular remodeling. These innovations highlight the industry's growing emphasis on biomimetic coatings, enhanced vessel healing, and long-term procedural safety.
Stroke Intervention Technologies Expand the Scope of Non-Coil Neurovascular Devices
Beyond aneurysm treatment, the market is benefiting from increasing adoption of mechanical devices for acute ischemic stroke intervention. Phenox received FDA clearance for its pRESET Delta and pRESET Delta LITE thrombectomy systems, expanding the range of available stent-retriever technologies used for clot removal in large intracranial arteries. These devices are engineered to mechanically engage and retrieve thromboembolic occlusions while supporting rapid restoration of cerebral blood flow during emergency stroke procedures. The growing integration of thrombectomy devices, flow diverters, embolization systems, and vessel reconstruction platforms demonstrates how the neuroendovascular non-coils industry is expanding beyond aneurysm management toward a broader neurovascular treatment ecosystem focused on minimally invasive intervention, procedural efficiency, and improved neurological outcomes.
Neuroendovascular Non-coils Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities
The global Neuroendovascular Non-coils market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Stryker Corporation, Medtronic plc, Johnson & Johnson MedTech (DePuy Synthes / Cerenovus), Terumo Corporation (MicroVention), Penumbra, Inc., Phenox GmbH (Wallaby Medical), Merit Medical Systems, Inc., MicroPort Scientific Corporation, Acandis GmbH, Balt USA LLC. The Neuroendovascular Non-coils market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Neuroendovascular Non-coils industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-
- Growth Neuroendovascular Non-coils Market size outlook across 3 scenarios- High growth, reference, and Low growth cases
- Market Trends, Drivers, Potential Opportunities, and Challenges faced by Neuroendovascular Non-coils companies
- Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry
- Detailed SWOT Analysis of global and regional Neuroendovascular Non-coils markets
- Competitive analysis including business description, product analysis, and financial profiles
- Key country specific analysis detailing key factors shaping the short-term and long-term outlook
- Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements
Leading companies in Neuroendovascular Non-coils industry include- Stryker Corporation, Medtronic plc, Johnson & Johnson MedTech (DePuy Synthes / Cerenovus), Terumo Corporation (MicroVention), Penumbra, Inc., Phenox GmbH (Wallaby Medical), Merit Medical Systems, Inc., MicroPort Scientific Corporation, Acandis GmbH, Balt USA LLC. The Neuroendovascular Non-coils market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.
What to expect in US Neuroendovascular Non-coils Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034
The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Neuroendovascular Non-coils market remains one of the strongest-performing segments in the country.
The US Neuroendovascular Non-coils Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Neuroendovascular Non-coils market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Neuroendovascular Non-coils industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.
Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Neuroendovascular Non-coils markets
Canada's strong Neuroendovascular Non-coils sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Neuroendovascular Non-coils market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.
Germany Neuroendovascular Non-coils Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.
Germany continues to remain the largest Neuroendovascular Non-coils market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Neuroendovascular Non-coils population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Neuroendovascular Non-coils industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Neuroendovascular Non-coils market outlook.
France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Neuroendovascular Non-coils sales through 2034
France Neuroendovascular Non-coils companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.
UK Neuroendovascular Non-coils Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain
Small high-need consumer segments remain key priority of Neuroendovascular Non-coils distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or ?280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was ?49 billion (14.1%) and voluntary health insurance was ?9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.
China Neuroendovascular Non-coils Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years
China Neuroendovascular Non-coils market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Neuroendovascular Non-coils industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Neuroendovascular Non-coils industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.
India Neuroendovascular Non-coils Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India
Indian Neuroendovascular Non-coils market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.
Brazil Neuroendovascular Non-coils market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities
Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.
Middle East and Africa Neuroendovascular Non-coils Industry Trends and Perspectives to 2034
According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.
Neuroendovascular Non-coils Market Segmentation
By Product Type
Neuroendovascular Stents
Flow Diversion Devices
Thrombectomy Devices
Access Devices
Liquid Embolic Agents
Embolic Protection Devices
Balloon Catheters
By Material
Nitinol-based Devices
Cobalt-chromium-based Devices
Polymer-based Devices
By Application
Ischemic Stroke Management
Intracranial Aneurysm Treatment
Arteriovenous Malformation (AVM) and Fistulas
Carotid Artery Disease
By End-User
Hospitals and Integrated Cath Labs
Dedicated Stroke Centers
Ambulatory Surgical Centers (ASCs)
Leading Companies in Neuroendovascular Non-coils Industry (2026)
Stryker Corporation
Medtronic plc
Johnson & Johnson MedTech (DePuy Synthes / Cerenovus)
Terumo Corporation (MicroVention)
Penumbra, Inc.
Phenox GmbH (Wallaby Medical)
Merit Medical Systems, Inc.
MicroPort Scientific Corporation
Acandis GmbH
Balt USA LLC
Countries Included
- North America- US, Canada, Mexico
- Europe- Germany, France, UK, Spain, Italy, Nordics, Others
- Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others
- Latin America- Brazil, Argentina, Others
- Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
- Get Free print authentication across single, multi, and global licenses
- Free Accompanying excel spreadsheet with complete quantitative data
- Free 2-day consulting support from the lead analyst of the team that developed the report
- Gain clear understanding of current market conditions across 20 countries and plan your decisions accordingly
- Understand competitive profiles of the leading 15 companies in the Electrosurgical Generators industry
- Stay ahead of competition through a detailed analysis of recent market developments
- Make trusted decisions building on our 10-year experience in developing reports on Electrosurgical Generators industry
CHAPTER 1- EXECUTIVE SUMMARY
1.1. Market Snapshot: Market Size, CAGR, and Growth Outlook to 2034
1.2. Key Industry Highlights, 2026
1.3. Premium Market Insights
1.3.1. Potential Neuroendovascular Non-coils Market Types and Applications
1.3.2. Fastest Growing Countries Over the forecast period
1.4. Market Scope and Segmentation
1.4.1. Key Market Segments
1.4.2. Key Countries and Regions
1.4.3. Top Companies in the Neuroendovascular Non-coils Industry
1.5. Macroeconomic and Demographic Outlook
1.5.1. GDP Outlook by Top 20 Countries, 2010- 2040
1.5.2. Population Forecast by Country, 2010- 2040
1.5.3. Inflation Trends in Leading Countries
1.6. Impact of Trade Policies, Regulations, and Sustainability
1.6.1. Trade tariffs and localization requirements
1.6.2. ESG and sustainability pressures
1.6.3. Compliance-driven structural changes in the value chain
CHAPTER 2- RESEARCH METHODOLOGY
2.1. Report Coverage
2.2. Secondary Research
2.3. Primary Research
2.4. Data Triangulation
2.5. Market Modeling and Forecasting
CHAPTER 3- GLOBAL NEUROENDOVASCULAR NON-COILS MARKET TRENDS, GROWTH DRIVERS, CHALLENGES, AND OPPORTUNITIES THROUGH 2034
3.1. An Introduction to Global Neuroendovascular Non-coils Markets in 2026
3.2. Global Historic and Forecast Neuroendovascular Non-coils Market Size Outlook, USD Million, 2021- 2034
3.3. Annual Market Size Growth Rate (Y-o-Y), %, 2021-2034
3.4. Market Dynamics
3.4.1. Key Neuroendovascular Non-coils Market Driving Forces and Their Impact on Market Outlook
3.4.2. Short and Long-Term Trends and Insights Shaping the Future
3.4.3. Potential Neuroendovascular Non-coils Market Opportunities for Industry Stakeholders
3.4.4. Potential Challenges across Neuroendovascular Non-coils Value Chain
CHAPTER 4- NEUROENDOVASCULAR NON-COILS MARKET COMPETITIVE LANDSCAPE, STRATEGIC ANALYSIS, AND VALUE CHAIN ASSESSMENT
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of Substitutes
4.1.4. Threat of New Entrants
4.1.5. Intensity of Competitive Rivalry
4.1.6. Market Attractiveness Analysis by Segment
4.1.7. Market Attractiveness Analysis by Region
4.2. Competitive Landscape
4.2.1 Market Share Analysis of Leading Neuroendovascular Non-coils Companies
4.2.2 Recent Strategic Developments
4.2.3 Mergers, Acquisitions, and Partnerships
4.2.4 Product Launches and Innovation Trends
4.2.5 Key Success Factors
4.3. Value Chain Analysis
4.3.1. Key Value Chain Segments
4.3.2. Dominant players by value-chain stage
4.4. SWOT Analysis
4.4.1. Key Strengths and Opportunities
4.4.2. Major Weaknesses and Threats
4.5 Technology Roadmap
4.6 Regulatory and Reimbursement Landscape
CHAPTER 5- NEUROENDOVASCULAR NON-COILS MARKET OUTLOOK BY SEGMENTS
5.1. Market Size Outlook by Type, USD Million, 2021- 2025 and 2026-2034
5.2. Market Size Outlook by Application, USD Million, 2021- 2025 and 2026-2034
5.3. Market Size Outlook by Country, USD Million, 2021- 2025 and 2026-2034
By Product Type
Neuroendovascular Stents
Flow Diversion Devices
Thrombectomy Devices
Access Devices
Liquid Embolic Agents
Embolic Protection Devices
Balloon Catheters
By Material
Nitinol-based Devices
Cobalt-chromium-based Devices
Polymer-based Devices
By Application
Ischemic Stroke Management
Intracranial Aneurysm Treatment
Arteriovenous Malformation (AVM) and Fistulas
Carotid Artery Disease
By End-User
Hospitals and Integrated Cath Labs
Dedicated Stroke Centers
Ambulatory Surgical Centers (ASCs)
CHAPTER 6- SCENARIO ANALYSIS AND OUTLOOK
6.1. Base Case Scenario
6.1.1. Definitions and Insights
6.1.2. Market Size Outlook to 2034
6.2. Low Growth Case Scenario
6.2.1. Definitions and Insights
6.2.2. Market Size Outlook to 2034
6.3. High Growth Case Scenario
6.3.1. Definitions and Insights
6.3.2. Market Size Outlook to 2034
CHAPTER 7- NORTH AMERICA NEUROENDOVASCULAR NON-COILS MARKET SIZE ANALYSIS AND OUTLOOK
7.1. North America Neuroendovascular Non-coils Market Overview, 2026
7.2. Leading Companies Operating in North America
7.3. Key Industry Statistics, 2026
7.4. North America Neuroendovascular Non-coils Market Trends and Growth Opportunities to 2034
7.5. North America Neuroendovascular Non-coils Market Size Outlook by Type
7.6. North America Neuroendovascular Non-coils Market Size Outlook by Application
7.7. North America Neuroendovascular Non-coils Market Size Outlook by Country
7.8. United States
7.8.1. Key Statistics
7.8.2. The US Neuroendovascular Non-coils Market Size Outlook, 2021- 2034
7.8.3. Key Market Drivers and Industry Developments in the US Neuroendovascular Non-coils Companies
7.9. Canada
7.9.1. Key Statistics
7.9.2. Canada Neuroendovascular Non-coils Market Size Outlook, 2021- 2034
7.9.3. Key Market Drivers and Industry Developments in Canada Neuroendovascular Non-coils Companies
7.10. Mexico
7.10.1. Key Statistics
7.10.2. Mexico Neuroendovascular Non-coils Market Size Outlook, 2021- 2034
7.10.3. Key Market Drivers and Industry Developments in Mexico Neuroendovascular Non-coils Companies
CHAPTER 8- EUROPE NEUROENDOVASCULAR NON-COILS MARKET SIZE ANALYSIS AND OUTLOOK
8.1. Europe Neuroendovascular Non-coils Market Overview, 2026
8.2. Leading Companies Operating in Europe
8.3. Key Industry Statistics, 2026
8.4. Europe Neuroendovascular Non-coils Market Trends and Growth Opportunities to 2034
8.5. Europe Neuroendovascular Non-coils Market Size Outlook by Type
8.6. Europe Neuroendovascular Non-coils Market Size Outlook by Application
8.7. Europe Neuroendovascular Non-coils Market Size Outlook by Country
8.8. Germany
8.8.1. Key Statistics
8.8.2. Germany Neuroendovascular Non-coils Market Size Outlook, 2021- 2034
8.8.3. Key Market Drivers and Industry Developments in Germany Neuroendovascular Non-coils Companies
8.9. France
8.9.1. Key Statistics
8.9.2. France Neuroendovascular Non-coils Market Size Outlook, 2021- 2034
8.9.3. Key Market Drivers and Industry Developments in France Neuroendovascular Non-coils Companies
8.10. United Kingdom
8.10.1. Key Statistics
8.10.2. United Kingdom Neuroendovascular Non-coils Market Size Outlook, 2021- 2034
8.10.3. Key Market Drivers and Industry Developments in the UK Neuroendovascular Non-coils Companies
8.11. Spain
8.11.1. Key Statistics
8.11.2. Spain Neuroendovascular Non-coils Market Size Outlook, 2021- 2034
8.11.3. Key Market Drivers and Industry Developments in Spain Neuroendovascular Non-coils Companies
8.12. Italy
8.12.1. Key Statistics
8.12.2. Italy Neuroendovascular Non-coils Market Size Outlook, 2021- 2034
8.12.3. Key Market Drivers and Industry Developments in Italy Neuroendovascular Non-coils Companies
8.13. Rest of Europe
8.13.1. Key Statistics
8.13.2. Rest of Europe Neuroendovascular Non-coils Market Size Outlook, 2021- 2034
8.13.3. Key Market Drivers and Industry Developments in Rest of Europe Neuroendovascular Non-coils Companies
CHAPTER 9- ASIA PACIFIC NEUROENDOVASCULAR NON-COILS MARKET SIZE ANALYSIS AND OUTLOOK
9.1. Asia Pacific Neuroendovascular Non-coils Market Overview, 2026
9.2. Leading Companies Operating in Asia Pacific
9.3. Key Industry Statistics, 2026
9.4. Asia Pacific Neuroendovascular Non-coils Market Trends and Growth Opportunities to 2034
9.5. Asia Pacific Neuroendovascular Non-coils Market Size Outlook by Type
9.6. Asia Pacific Neuroendovascular Non-coils Market Size Outlook by Application
9.7. Asia Pacific Neuroendovascular Non-coils Market Size Outlook by Country
9.8. China
9.8.1. Key Statistics
9.8.2. China Neuroendovascular Non-coils Market Size Outlook, 2021- 2034
9.8.3. Key Market Drivers and Industry Developments in China Neuroendovascular Non-coils Companies
9.9. Japan
9.9.1. Key Statistics
9.9.2. Japan Neuroendovascular Non-coils Market Size Outlook, 2021- 2034
9.9.3. Key Market Drivers and Industry Developments in Japan Neuroendovascular Non-coils Companies
9.10. India
9.10.1. Key Statistics
9.10.2. India Neuroendovascular Non-coils Market Size Outlook, 2021- 2034
9.10.3. Key Market Drivers and Industry Developments in India Neuroendovascular Non-coils Companies
9.11. South Korea
9.11.1. Key Statistics
9.11.2. South Korea Neuroendovascular Non-coils Market Size Outlook, 2021- 2034
9.11.3. Key Market Drivers and Industry Developments in South Korea Neuroendovascular Non-coils Companies
9.12. Australia
9.12.1. Key Statistics
9.12.2. Australia Neuroendovascular Non-coils Market Size Outlook, 2021- 2034
9.12.3. Key Market Drivers and Industry Developments in Australia Neuroendovascular Non-coils Companies
9.13. Southeast Asia
9.13.1. Key Statistics
9.13.2. Southeast Asia Neuroendovascular Non-coils Market Size Outlook, 2021- 2034
9.13.3. Key Market Drivers and Industry Developments in Southeast Asia Neuroendovascular Non-coils Companies
CHAPTER 10- SOUTH AND CENTRAL AMERICA NEUROENDOVASCULAR NON-COILS MARKET SIZE ANALYSIS AND OUTLOOK
10.1. South and Central America Neuroendovascular Non-coils Market Overview, 2026
10.2. Leading Companies Operating in South and Central America
10.3. Key Industry Statistics, 2026
10.4. South and Central America Neuroendovascular Non-coils Market Trends and Growth Opportunities to 2034
10.5. South and Central America Neuroendovascular Non-coils Market Size Outlook by Type
10.6. South and Central America Neuroendovascular Non-coils Market Size Outlook by Application
10.7. South and Central America Neuroendovascular Non-coils Market Size Outlook by Country
10.8. Brazil
10.8.1. Key Statistics
10.8.2. Brazil Neuroendovascular Non-coils Market Size Outlook, 2021- 2034
10.8.3. Key Market Drivers and Industry Developments in Brazil Neuroendovascular Non-coils Companies
10.9. Argentina
10.9.1. Key Statistics
10.9.2. Argentina Neuroendovascular Non-coils Market Size Outlook, 2021- 2034
10.9.3. Key Market Drivers and Industry Developments in Argentina Neuroendovascular Non-coils Companies
10.10. Rest of Latin America
10.10.1. Key Statistics
10.10.2. Rest of Latin America Neuroendovascular Non-coils Market Size Outlook, 2021- 2034
10.10.3. Key Market Drivers and Industry Developments in Rest of Latin America Neuroendovascular Non-coils Companies
CHAPTER 11- MIDDLE EAST AND AFRICA NEUROENDOVASCULAR NON-COILS MARKET SIZE ANALYSIS AND OUTLOOK
11.1. Middle East and Africa Neuroendovascular Non-coils Market Overview, 2026
11.2. Leading Companies Operating in Middle East and Africa
11.3. Key Industry Statistics, 2026
11.4. Middle East and Africa Neuroendovascular Non-coils Market Trends and Growth Opportunities to 2034
11.5. Middle East and Africa Neuroendovascular Non-coils Market Size Outlook by Type
11.6. Middle East and Africa Neuroendovascular Non-coils Market Size Outlook by Application
11.7. Middle East and Africa Neuroendovascular Non-coils Market Size Outlook by Country
11.8. Saudi Arabia
11.8.1. Key Statistics
11.8.2. Saudi Arabia Neuroendovascular Non-coils Market Size Outlook, 2021- 2034
11.8.3. Key Market Drivers and Industry Developments in Saudi Arabia Neuroendovascular Non-coils Companies
11.9. United Arab Emirates
11.9.1. Key Statistics
11.9.2. The UAE Neuroendovascular Non-coils Market Size Outlook, 2021- 2034
11.9.3. Key Market Drivers and Industry Developments in the UAE Neuroendovascular Non-coils Companies
11.10. Africa
11.10.1. Key Statistics
11.10.2. Africa Neuroendovascular Non-coils Market Size Outlook, 2021- 2034
11.10.3. Key Market Drivers and Industry Developments in Africa Neuroendovascular Non-coils Companies
CHAPTER 12- COMPANY PROFILES
12.1. Top Companies in Neuroendovascular Non-coils Industry
Stryker Corporation
Medtronic plc
Johnson & Johnson MedTech (DePuy Synthes / Cerenovus)
Terumo Corporation (MicroVention)
Penumbra, Inc.
Phenox GmbH (Wallaby Medical)
Merit Medical Systems, Inc.
MicroPort Scientific Corporation
Acandis GmbH
Balt USA LLC
12.2. Business Description
12.3. SWOT Profiles
12.4. Products and Services
CHAPTER 13- APPENDIX
Glossary of Terms
Research Methodology & Data Sources
Conclusion & Strategic Recommendations
1.1. Market Snapshot: Market Size, CAGR, and Growth Outlook to 2034
1.2. Key Industry Highlights, 2026
1.3. Premium Market Insights
1.3.1. Potential Neuroendovascular Non-coils Market Types and Applications
1.3.2. Fastest Growing Countries Over the forecast period
1.4. Market Scope and Segmentation
1.4.1. Key Market Segments
1.4.2. Key Countries and Regions
1.4.3. Top Companies in the Neuroendovascular Non-coils Industry
1.5. Macroeconomic and Demographic Outlook
1.5.1. GDP Outlook by Top 20 Countries, 2010- 2040
1.5.2. Population Forecast by Country, 2010- 2040
1.5.3. Inflation Trends in Leading Countries
1.6. Impact of Trade Policies, Regulations, and Sustainability
1.6.1. Trade tariffs and localization requirements
1.6.2. ESG and sustainability pressures
1.6.3. Compliance-driven structural changes in the value chain
CHAPTER 2- RESEARCH METHODOLOGY
2.1. Report Coverage
2.2. Secondary Research
2.3. Primary Research
2.4. Data Triangulation
2.5. Market Modeling and Forecasting
CHAPTER 3- GLOBAL NEUROENDOVASCULAR NON-COILS MARKET TRENDS, GROWTH DRIVERS, CHALLENGES, AND OPPORTUNITIES THROUGH 2034
3.1. An Introduction to Global Neuroendovascular Non-coils Markets in 2026
3.2. Global Historic and Forecast Neuroendovascular Non-coils Market Size Outlook, USD Million, 2021- 2034
3.3. Annual Market Size Growth Rate (Y-o-Y), %, 2021-2034
3.4. Market Dynamics
3.4.1. Key Neuroendovascular Non-coils Market Driving Forces and Their Impact on Market Outlook
3.4.2. Short and Long-Term Trends and Insights Shaping the Future
3.4.3. Potential Neuroendovascular Non-coils Market Opportunities for Industry Stakeholders
3.4.4. Potential Challenges across Neuroendovascular Non-coils Value Chain
CHAPTER 4- NEUROENDOVASCULAR NON-COILS MARKET COMPETITIVE LANDSCAPE, STRATEGIC ANALYSIS, AND VALUE CHAIN ASSESSMENT
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of Substitutes
4.1.4. Threat of New Entrants
4.1.5. Intensity of Competitive Rivalry
4.1.6. Market Attractiveness Analysis by Segment
4.1.7. Market Attractiveness Analysis by Region
4.2. Competitive Landscape
4.2.1 Market Share Analysis of Leading Neuroendovascular Non-coils Companies
4.2.2 Recent Strategic Developments
4.2.3 Mergers, Acquisitions, and Partnerships
4.2.4 Product Launches and Innovation Trends
4.2.5 Key Success Factors
4.3. Value Chain Analysis
4.3.1. Key Value Chain Segments
4.3.2. Dominant players by value-chain stage
4.4. SWOT Analysis
4.4.1. Key Strengths and Opportunities
4.4.2. Major Weaknesses and Threats
4.5 Technology Roadmap
4.6 Regulatory and Reimbursement Landscape
CHAPTER 5- NEUROENDOVASCULAR NON-COILS MARKET OUTLOOK BY SEGMENTS
5.1. Market Size Outlook by Type, USD Million, 2021- 2025 and 2026-2034
5.2. Market Size Outlook by Application, USD Million, 2021- 2025 and 2026-2034
5.3. Market Size Outlook by Country, USD Million, 2021- 2025 and 2026-2034
By Product Type
Neuroendovascular Stents
Flow Diversion Devices
Thrombectomy Devices
Access Devices
Liquid Embolic Agents
Embolic Protection Devices
Balloon Catheters
By Material
Nitinol-based Devices
Cobalt-chromium-based Devices
Polymer-based Devices
By Application
Ischemic Stroke Management
Intracranial Aneurysm Treatment
Arteriovenous Malformation (AVM) and Fistulas
Carotid Artery Disease
By End-User
Hospitals and Integrated Cath Labs
Dedicated Stroke Centers
Ambulatory Surgical Centers (ASCs)
CHAPTER 6- SCENARIO ANALYSIS AND OUTLOOK
6.1. Base Case Scenario
6.1.1. Definitions and Insights
6.1.2. Market Size Outlook to 2034
6.2. Low Growth Case Scenario
6.2.1. Definitions and Insights
6.2.2. Market Size Outlook to 2034
6.3. High Growth Case Scenario
6.3.1. Definitions and Insights
6.3.2. Market Size Outlook to 2034
CHAPTER 7- NORTH AMERICA NEUROENDOVASCULAR NON-COILS MARKET SIZE ANALYSIS AND OUTLOOK
7.1. North America Neuroendovascular Non-coils Market Overview, 2026
7.2. Leading Companies Operating in North America
7.3. Key Industry Statistics, 2026
7.4. North America Neuroendovascular Non-coils Market Trends and Growth Opportunities to 2034
7.5. North America Neuroendovascular Non-coils Market Size Outlook by Type
7.6. North America Neuroendovascular Non-coils Market Size Outlook by Application
7.7. North America Neuroendovascular Non-coils Market Size Outlook by Country
7.8. United States
7.8.1. Key Statistics
7.8.2. The US Neuroendovascular Non-coils Market Size Outlook, 2021- 2034
7.8.3. Key Market Drivers and Industry Developments in the US Neuroendovascular Non-coils Companies
7.9. Canada
7.9.1. Key Statistics
7.9.2. Canada Neuroendovascular Non-coils Market Size Outlook, 2021- 2034
7.9.3. Key Market Drivers and Industry Developments in Canada Neuroendovascular Non-coils Companies
7.10. Mexico
7.10.1. Key Statistics
7.10.2. Mexico Neuroendovascular Non-coils Market Size Outlook, 2021- 2034
7.10.3. Key Market Drivers and Industry Developments in Mexico Neuroendovascular Non-coils Companies
CHAPTER 8- EUROPE NEUROENDOVASCULAR NON-COILS MARKET SIZE ANALYSIS AND OUTLOOK
8.1. Europe Neuroendovascular Non-coils Market Overview, 2026
8.2. Leading Companies Operating in Europe
8.3. Key Industry Statistics, 2026
8.4. Europe Neuroendovascular Non-coils Market Trends and Growth Opportunities to 2034
8.5. Europe Neuroendovascular Non-coils Market Size Outlook by Type
8.6. Europe Neuroendovascular Non-coils Market Size Outlook by Application
8.7. Europe Neuroendovascular Non-coils Market Size Outlook by Country
8.8. Germany
8.8.1. Key Statistics
8.8.2. Germany Neuroendovascular Non-coils Market Size Outlook, 2021- 2034
8.8.3. Key Market Drivers and Industry Developments in Germany Neuroendovascular Non-coils Companies
8.9. France
8.9.1. Key Statistics
8.9.2. France Neuroendovascular Non-coils Market Size Outlook, 2021- 2034
8.9.3. Key Market Drivers and Industry Developments in France Neuroendovascular Non-coils Companies
8.10. United Kingdom
8.10.1. Key Statistics
8.10.2. United Kingdom Neuroendovascular Non-coils Market Size Outlook, 2021- 2034
8.10.3. Key Market Drivers and Industry Developments in the UK Neuroendovascular Non-coils Companies
8.11. Spain
8.11.1. Key Statistics
8.11.2. Spain Neuroendovascular Non-coils Market Size Outlook, 2021- 2034
8.11.3. Key Market Drivers and Industry Developments in Spain Neuroendovascular Non-coils Companies
8.12. Italy
8.12.1. Key Statistics
8.12.2. Italy Neuroendovascular Non-coils Market Size Outlook, 2021- 2034
8.12.3. Key Market Drivers and Industry Developments in Italy Neuroendovascular Non-coils Companies
8.13. Rest of Europe
8.13.1. Key Statistics
8.13.2. Rest of Europe Neuroendovascular Non-coils Market Size Outlook, 2021- 2034
8.13.3. Key Market Drivers and Industry Developments in Rest of Europe Neuroendovascular Non-coils Companies
CHAPTER 9- ASIA PACIFIC NEUROENDOVASCULAR NON-COILS MARKET SIZE ANALYSIS AND OUTLOOK
9.1. Asia Pacific Neuroendovascular Non-coils Market Overview, 2026
9.2. Leading Companies Operating in Asia Pacific
9.3. Key Industry Statistics, 2026
9.4. Asia Pacific Neuroendovascular Non-coils Market Trends and Growth Opportunities to 2034
9.5. Asia Pacific Neuroendovascular Non-coils Market Size Outlook by Type
9.6. Asia Pacific Neuroendovascular Non-coils Market Size Outlook by Application
9.7. Asia Pacific Neuroendovascular Non-coils Market Size Outlook by Country
9.8. China
9.8.1. Key Statistics
9.8.2. China Neuroendovascular Non-coils Market Size Outlook, 2021- 2034
9.8.3. Key Market Drivers and Industry Developments in China Neuroendovascular Non-coils Companies
9.9. Japan
9.9.1. Key Statistics
9.9.2. Japan Neuroendovascular Non-coils Market Size Outlook, 2021- 2034
9.9.3. Key Market Drivers and Industry Developments in Japan Neuroendovascular Non-coils Companies
9.10. India
9.10.1. Key Statistics
9.10.2. India Neuroendovascular Non-coils Market Size Outlook, 2021- 2034
9.10.3. Key Market Drivers and Industry Developments in India Neuroendovascular Non-coils Companies
9.11. South Korea
9.11.1. Key Statistics
9.11.2. South Korea Neuroendovascular Non-coils Market Size Outlook, 2021- 2034
9.11.3. Key Market Drivers and Industry Developments in South Korea Neuroendovascular Non-coils Companies
9.12. Australia
9.12.1. Key Statistics
9.12.2. Australia Neuroendovascular Non-coils Market Size Outlook, 2021- 2034
9.12.3. Key Market Drivers and Industry Developments in Australia Neuroendovascular Non-coils Companies
9.13. Southeast Asia
9.13.1. Key Statistics
9.13.2. Southeast Asia Neuroendovascular Non-coils Market Size Outlook, 2021- 2034
9.13.3. Key Market Drivers and Industry Developments in Southeast Asia Neuroendovascular Non-coils Companies
CHAPTER 10- SOUTH AND CENTRAL AMERICA NEUROENDOVASCULAR NON-COILS MARKET SIZE ANALYSIS AND OUTLOOK
10.1. South and Central America Neuroendovascular Non-coils Market Overview, 2026
10.2. Leading Companies Operating in South and Central America
10.3. Key Industry Statistics, 2026
10.4. South and Central America Neuroendovascular Non-coils Market Trends and Growth Opportunities to 2034
10.5. South and Central America Neuroendovascular Non-coils Market Size Outlook by Type
10.6. South and Central America Neuroendovascular Non-coils Market Size Outlook by Application
10.7. South and Central America Neuroendovascular Non-coils Market Size Outlook by Country
10.8. Brazil
10.8.1. Key Statistics
10.8.2. Brazil Neuroendovascular Non-coils Market Size Outlook, 2021- 2034
10.8.3. Key Market Drivers and Industry Developments in Brazil Neuroendovascular Non-coils Companies
10.9. Argentina
10.9.1. Key Statistics
10.9.2. Argentina Neuroendovascular Non-coils Market Size Outlook, 2021- 2034
10.9.3. Key Market Drivers and Industry Developments in Argentina Neuroendovascular Non-coils Companies
10.10. Rest of Latin America
10.10.1. Key Statistics
10.10.2. Rest of Latin America Neuroendovascular Non-coils Market Size Outlook, 2021- 2034
10.10.3. Key Market Drivers and Industry Developments in Rest of Latin America Neuroendovascular Non-coils Companies
CHAPTER 11- MIDDLE EAST AND AFRICA NEUROENDOVASCULAR NON-COILS MARKET SIZE ANALYSIS AND OUTLOOK
11.1. Middle East and Africa Neuroendovascular Non-coils Market Overview, 2026
11.2. Leading Companies Operating in Middle East and Africa
11.3. Key Industry Statistics, 2026
11.4. Middle East and Africa Neuroendovascular Non-coils Market Trends and Growth Opportunities to 2034
11.5. Middle East and Africa Neuroendovascular Non-coils Market Size Outlook by Type
11.6. Middle East and Africa Neuroendovascular Non-coils Market Size Outlook by Application
11.7. Middle East and Africa Neuroendovascular Non-coils Market Size Outlook by Country
11.8. Saudi Arabia
11.8.1. Key Statistics
11.8.2. Saudi Arabia Neuroendovascular Non-coils Market Size Outlook, 2021- 2034
11.8.3. Key Market Drivers and Industry Developments in Saudi Arabia Neuroendovascular Non-coils Companies
11.9. United Arab Emirates
11.9.1. Key Statistics
11.9.2. The UAE Neuroendovascular Non-coils Market Size Outlook, 2021- 2034
11.9.3. Key Market Drivers and Industry Developments in the UAE Neuroendovascular Non-coils Companies
11.10. Africa
11.10.1. Key Statistics
11.10.2. Africa Neuroendovascular Non-coils Market Size Outlook, 2021- 2034
11.10.3. Key Market Drivers and Industry Developments in Africa Neuroendovascular Non-coils Companies
CHAPTER 12- COMPANY PROFILES
12.1. Top Companies in Neuroendovascular Non-coils Industry
Stryker Corporation
Medtronic plc
Johnson & Johnson MedTech (DePuy Synthes / Cerenovus)
Terumo Corporation (MicroVention)
Penumbra, Inc.
Phenox GmbH (Wallaby Medical)
Merit Medical Systems, Inc.
MicroPort Scientific Corporation
Acandis GmbH
Balt USA LLC
12.2. Business Description
12.3. SWOT Profiles
12.4. Products and Services
CHAPTER 13- APPENDIX
Glossary of Terms
Research Methodology & Data Sources
Conclusion & Strategic Recommendations
